Pulmonary Adenosquamous Carcinoma
1 clinical trials · Condition
◉ Watch Pulmonary Adenosquamous Carcinoma
| Record | Firm | Date |
|---|---|---|
| Almonertinib as First-line Treatment in Patients With EGFR+ Positive Pulmonary Adenosquamous Carcinoma or Combined Adenocarcinoma and Squamous Cell Carcinoma (NCT04354961) | Fujian Cancer Hospital | 2021-05-07 |
Track Pulmonary Adenosquamous Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.